Emicizumab in people with moderate or mild haemophilia AHAVEN 6 a multicentre open label singlearm phase 3 study

Simple item page
dc.article.end-page177en
dc.article.start-page168en
dc.citation.doi10.1016/S2352-3026(22)00377-5en
dc.contributor.authorC Negrieren
dc.contributor.authorJohnny Mahlanguen
dc.contributor.authorM Lehleen
dc.contributor.authorP Chowdaryen
dc.contributor.authorOlivier Catalanien
dc.contributor.authorE et alen
dc.date.accessioned2024-07-23T05:55:18Z
dc.date.available2024-07-23T05:55:18Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn2352-3026en
dc.identifier.urihttps://hdl.handle.net/10539/39120
dc.journal.titleEmicizumab in people with moderate or mild haemophilia AHAVEN 6 a multicentre open label singlearm phase 3 studyen
dc.journal.volume10en
dc.publisherWILEY-BLACKWELLen
dc.titleEmicizumab in people with moderate or mild haemophilia AHAVEN 6 a multicentre open label singlearm phase 3 studyen
dc.typeJournal Articleen
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
472.74 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download
Collections
Academic Wits Research Outputs (All submissions)